OctoPlus N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
23 jun 2009 - 07:29
Statutaire naam
OctoPlus N.V.
Titel
OctoPlus opens new GMP manufacturing facility
Bericht
OctoPlus N.V. (“OctoPlus” or the “Company”) (Euronext: OCTO) announces today that it has started pharmaceutical production in its new manufacturing facility in Leiden. The facility has received a license from the Dutch authorities to manufacture pharmaceutical products according to international GMP (Good Manufacturing Practice) guidelines and the first production has taken place successfully.
Gerelateerde downloads
Datum laatste update: 28 juli 2024